TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Rosen Law Firm is investigating potential securities claims for Soleno Therapeutics shareholders following a Scorpion Capital short report that raised concerns about their Prader-Willi syndrome treatment, VYKAT XR.

Insights
AIEQ   neutral

Lowest performance of the three with 20.6% gain, uses IBM Watson to select stocks, provides unique AI-driven selection approach


SLNO   negative

Stock fell 7.4% and 4.9% on consecutive trading days after a short report suggested potential safety issues and risk of market withdrawal for their drug VYKAT XR